Search research articles
Contact Us
Filters
Showing results (121-130 of 220) with videos related to
Page
of 22
Sort By:
American Journal of Nephrology
|
March 14, 2008
Is fetuin-A/alpha2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?
Jonas Axelsson, Xin Wang, Markus Ketteler, et al.
Advances in Therapy
|
June 24, 2021
Risk of Cardiovascular Conditions in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study
Elvira O Gosmanova, Kristina Chen, Markus Ketteler, et al.
Biodata Mining
|
March 17, 2023
Algorithm-based detection of acute kidney injury according to full KDIGO criteria including urine output following cardiac surgery: a descriptive analysis
Nico Schmid, Mihnea Ghinescu, Moritz Schanz, et al.
Calcified Tissue International
|
August 12, 2025
Consensus-Based Recommendations for the Diagnosis, Treatment, and Monitoring of Hypoparathyroidism: Insights from the DACH Region
Elena Tsourdi, Karin Amrein, Christian Meier, et al.
Kidney International
|
February 9, 2005
Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification
Rajnish Mehrotra, Ralf Westenfeld, Peter Christenson, et al.
Journal of Cardiovascular Electrophysiology
|
April 15, 2011
Renal dysfunction and atrial fibrillation recurrence following cardioversion
Martin Schmidt, Marcos Daccarett, Harald Rittger, et al.
Kidney International
|
March 23, 2005
IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly
Peter Stenvinkel, Markus Ketteler, Richard J Johnson, et al.
Journal of the American Society of Nephrology : JASN
|
September 2, 2004
Inducible nitric oxide synthase-derived nitric oxide promotes glomerular angiogenesis via upregulation of vascular endothelial growth factor receptors
Tammo Ostendorf, Claudia Van Roeyen, Ralf Westenfeld, et al.
The Journal of Clinical Investigation
|
August 5, 2003
The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
Cora Schafer, Alexander Heiss, Anke Schwarz, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
May 3, 2008
Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis
Markus Ketteler, Marianne Rix, Stanley Fan, et al.
Page
of 22
Search research articles
Search
Showing results (121-130 of 220) with videos related to
Sort By:
Page
of 22
American Journal of Nephrology
|
March 14, 2008
Is fetuin-A/alpha2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?
Jonas Axelsson, Xin Wang, Markus Ketteler, et al.
Advances in Therapy
|
June 24, 2021
Risk of Cardiovascular Conditions in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study
Elvira O Gosmanova, Kristina Chen, Markus Ketteler, et al.
Biodata Mining
|
March 17, 2023
Algorithm-based detection of acute kidney injury according to full KDIGO criteria including urine output following cardiac surgery: a descriptive analysis
Nico Schmid, Mihnea Ghinescu, Moritz Schanz, et al.
Calcified Tissue International
|
August 12, 2025
Consensus-Based Recommendations for the Diagnosis, Treatment, and Monitoring of Hypoparathyroidism: Insights from the DACH Region
Elena Tsourdi, Karin Amrein, Christian Meier, et al.
Kidney International
|
February 9, 2005
Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification
Rajnish Mehrotra, Ralf Westenfeld, Peter Christenson, et al.
Journal of Cardiovascular Electrophysiology
|
April 15, 2011
Renal dysfunction and atrial fibrillation recurrence following cardioversion
Martin Schmidt, Marcos Daccarett, Harald Rittger, et al.
Kidney International
|
March 23, 2005
IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly
Peter Stenvinkel, Markus Ketteler, Richard J Johnson, et al.
Journal of the American Society of Nephrology : JASN
|
September 2, 2004
Inducible nitric oxide synthase-derived nitric oxide promotes glomerular angiogenesis via upregulation of vascular endothelial growth factor receptors
Tammo Ostendorf, Claudia Van Roeyen, Ralf Westenfeld, et al.
The Journal of Clinical Investigation
|
August 5, 2003
The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
Cora Schafer, Alexander Heiss, Anke Schwarz, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
May 3, 2008
Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis
Markus Ketteler, Marianne Rix, Stanley Fan, et al.
Page
of 22